Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Muscle relaxants Stories

2007-12-09 06:00:09

By Bennett, W R Murray Wilson, Lawrence G; Roy-Byrne, Peter P Abstract- GHB is an increasingly popular drug of abuse that can be associated in select cases with growing dependence and a severe withdrawal syndrome. While benzodiazepines are recommended for treatment of the withdrawal syndrome, some cases have been described as benzodiazepine-resistant. The authors describe treatment of such a case, which was unsuccessfully treated initially with benzodiazepines, then successfully treated...

2006-06-21 08:00:00

By Bill Berkrot NEW YORK -- An experimental insomnia drug being developed by Merck & Co. and Danish drug maker H. Lundbeck A/S showed promise in helping patients achieve deep sleep in small mid-stage clinical studies, the companies said on Wednesday. Statistically significant increases in deep sleep were seen with gaboxadol at all four tested doses compared to a placebo, but the drug appeared to be more effective at the higher 10 milligram, 15 mg, and 20 mg than at the lowest 5 mg dose,...

2005-12-11 09:26:18

Ambien, Lunesta and Sonata all have their pluses and minuses, study found HealthDay News -- No single sleeping pill stands out as the best, according to a U.S. review of the newer sleep aids on the market. The researchers reviewed 141 studies of the sleeping pills Sonata, Ambien, Lunesta and a Canadian brand called Imovane. These are all considered newer sleeping aids and are commonly prescribed for insomnia in place of older benzodiazepine sleeping aids such as Halcion, ProSom and Restoril....

2005-11-11 15:28:04

NEW YORK (Reuters Health) - While sedative drugs, such as Restoril and Ambien, may improve sleep in older people with insomnia, the risks of such therapy may outweigh the benefits, according to investigators in Canada. The findings are based on a review of 24 trials that included 2417 subjects aged 60 or older who were treated with so-called sedative hypnotic pills or inactive placebo pills for insomnia. The subjects received the assigned pills for at least five consecutive nights....

2005-06-25 10:07:53

In trial, ramelteon helped users doze off and sleep longer HealthDay News -- The investigational drug ramelteon reduced the time it took for people with chronic insomnia to fall asleep and also increased their total sleep time, according to the results of a Phase III study sponsored by the drug's maker, Takeda Pharmaceuticals. The study also found no evidence of rebound insomnia, next-day impairments or withdrawal effects after people stopped using the drug. The U.S. Food and Drug...

2005-06-20 22:38:45

Denver, CO, June 20, 2005 "“ Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS). Results of the study also showed no evidence of rebound insomnia, next-day impairments or withdrawal effects due...

2005-06-14 18:41:18

A team of researchers from the Department of Biochemistry and Molecular Biology and the Institute of Neuroscience at the Universitat Autònoma de Barcelona has discovered that tetanus toxin, which causes tetanus, could be extremely useful as a therapy against psychological disorders such as depression, anxiety and anorexia, and to slow the progress of neurodegenerative disorders such as Parkinson's disease. Tetanus toxin is a neurotoxin belonging to the same family as...